Market Place
Sourcing Support
All News #Library
Others
NKMax Announces SNK01 Abstract Accepted for (SITC) 2021 Annual Meeting
04 Oct 2021 //
GLOBENEWSWIRE
NKMax Announces SNK01 Abstract Accepted for (SITC) 2021 Annual Meeting
04 Oct 2021 //
GLOBENEWSWIRE
NKMax, Merck expand clinical collaboration to include phase I/IIa trial of SNK01
14 Apr 2021 //
PHARMABIZ
NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration
13 Apr 2021 //
GLOBENEWSWIRE
NKMax America Announces Corporate Name Change to NKGen Biotech
02 Apr 2021 //
GLOBENEWSWIRE
Affimed and NKMax America Announce FDA Clearance of IND Application to Study
31 Mar 2021 //
PRESS RELEASE
NKMax America Receives FDA Clearance to Amend its Current Monotherapy Trial
31 Aug 2020 //
GLOBENEWSWIRE
NKMax America Receives FDA Clearance of IND for PhI/2a Trial of NKCT (SNK01)
02 Jun 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.